Evidence map›Paper›PMID 37179999›Full record

ReviewRSC advances2023

2-Oxindole and related heterocycles: synthetic methodologies for their natural products and related derivatives.

Shivangi Sharma, Yukti Monga, Ashu Gupta, Shivendra Singh

Abstract readReview
In one paragraph

Review in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A novel ene-reductase fromRSC advances · 2025
    Article
  8. Review
  9. Article
  10. Natural Products from Herbal Medicine Self-Assemble into Advanced Bioactive Materials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  11. Article
  12. Heterocyclic-Based Analogues against Sarcine-Ricin Loop RNA fromMedicinal chemistry (Shariqah (United Arab Emirates)) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shivangi SharmaDepartment of Applied Chemistry, Amity School of Engineering and Technology, Amity University Madhya Pradesh Gwalior Madhya Pradesh-474 005 India shivendrasngh0@gmail.com.ORCID https://orcid.org/0000-0001-9339-0244
Yukti MongaShyamlal College, Department of Chemistry, University of Delhi Delhi-110032 India.ORCID https://orcid.org/0000-0002-6959-6960
Ashu GuptaShyamlal College, Department of Chemistry, University of Delhi Delhi-110032 India.ORCID https://orcid.org/0000-0002-7717-3124
Shivendra SinghDepartment of Applied Chemistry, Amity School of Engineering and Technology, Amity University Madhya Pradesh Gwalior Madhya Pradesh-474 005 India shivendrasngh0@gmail.com.ORCID https://orcid.org/0000-0002-7537-1186

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural goods, medications, and pharmaceutically active substances all contain substituted oxindoles. Generally, the C-3 stereocenter of the substituents of oxindoles and their absolute arrangement have a substantial impact on the bioactivity of these substances. In this case, the desire for contemporary probe and drug-discovery programs for the synthesis of chiral compounds using desirable scaffolds with high structural diversity further drives research in this field. Also, the new synthetic techniques are generally simple to apply for the synthesis of other similar scaffolds. Herein, we review the distinct approaches for the synthesis of diverse useful oxindole scaffolds. Specifically, the research findings on the naturally existing 2-oxindole core and a variety of synthetic compounds having a 2-oxindole core are discussed. We present an overview of the construction of oxindole-based synthetic and natural products. In addition, the chemical reactivity of 2-oxindole and its related derivatives in the presence of chiral and achiral catalysts are thoroughly discussed. The data compiled herein provides broad information related to the bioactive product design, development, and applications of 2-oxindoles and the reported techniques will be helpful for the investigation of novel reactions in the future.

Identifiers

PMID37179999
PMCPMC10173257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.